Contact Us
Hormone Therapy Global Market Report 2025
Global Hormone Therapy Market Report 2025

Report Price : $4490.00

Pages : 200

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF
Purchase This Report

Hormone Therapy Global Market Report 2025

By Therapy (Estrogen Hormone Replacement, Growth Hormone Replacement, Thyroid Hormone Replacement, Testosterone Replacement), By Route of Administration (Oral, Parenteral, Other Routes of Administration), By Indication (Menopause, Hypothyroidism, Growth Hormone Deficiency, Other Indications), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies And Stores, Online Pharmacies) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Hormone Therapy Market Overview

• Hormone Therapy market size has reached to $19.7 billion in 2024

• Expected to grow to $27.83 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%

• Growth Driver: Surge In Hormone Imbalance Disorders Fuels Growth Of Hormone Therapy Market

• Market Trend: Innovative Direct-To-Consumer Telehealth Solutions Revolutionizing Hormone Therapy Accessibility

North America was the largest region in 2024.

What Is Covered Under Hormone Therapy Market?

Hormone therapy refers to a kind of treatment that alters, suppresses, or increases certain hormones in the body. Hormone therapy is used to treat hormonal imbalances such as hypothyroidism, and others.

The main therapies of hormone therapy are estrogen hormone replacement, growth hormone replacement, thyroid hormone replacement, and testosterone replacement. Estrogen hormone replacement therapy refers to treatment with the hormone estrogen to boost the body's level of estrogen. Oral, parenteral, and other routes of administration are used in indications such as menopause, hypothyroidism, growth hormone deficiency, and others, with distribution channels such as hospital pharmacies, retail pharmacies, and online pharmacies.

Hormone Therapy Global Market Report 2025 Market Size and growth rate 2025 to 2029: Graph

What Is The Hormone Therapy Market Size 2025 And Growth Rate?

The hormone therapy market size has grown strongly in recent years. It will grow from $19.7 billion in 2024 to $20.9 billion in 2025 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to medical advancements, women's health revolution, increased awareness and education, clinical research and development, shifting healthcare practices.

What Is The Hormone Therapy Market Growth Forecast?

The hormone therapy market size is expected to see strong growth in the next few years. It will grow to $27.83 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to personalized medicine approach, aging population dynamics, shift in women's health approaches, focus on wellness and longevity, regulatory adaptations. Major trends in the forecast period include regulatory changes and guidelines, changing lifestyles and stress, research and development, expanding awareness and education.

The forecast of 7.4% growth over the next five years reflects a modest reduction of 0.3% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions may burden U.S. endocrinology clinics by inflating costs of bioidentical hormone preparations and hormone level testing reagents imported from Canada and Sweden, increasing menopause and gender-affirming care expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Hormone Therapy Market Segmented?

1) By Therapy: Estrogen Hormone Replacement, Growth Hormone Replacement, Thyroid Hormone Replacement, Testosterone Replacement

2) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration

3) By Indication: Menopause, Hypothyroidism, Growth Hormone Deficiency, Other Indications

4) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies And Stores, Online Pharmacies

Subsegments:

1) By Estrogen Hormone Replacement: Systemic Estrogen Therapy, Local Estrogen Therapy, Combination Estrogen-Progestin Therapy

2) By Growth Hormone Replacement: Recombinant Growth Hormones, Synthetic Growth Hormones

3) By Thyroid Hormone Replacement: Levothyroxine, Liothyronine, Natural Desiccated Thyroid

4) By Testosterone Replacement: Injectable Testosterone, Transdermal Testosterone, Oral Testosterone, Pellets

What Is Driving The Hormone Therapy Market? Surge In Hormone Imbalance Disorders Fuels Growth Of Hormone Therapy Market

A surge in the incidences of hormone imbalance disorders is significantly contributing to the growth of the hormone therapy market going forward. Hormone imbalance refers to the condition where the body produces either too much or too little of a hormone. Various hormone imbalance disorders include hypothyroidism, hypogonadism, growth hormone deficiency, and so on. Hormone therapies such as estrogen replacement, testosterone replacement, and insulin therapy are used to treat hormone imbalance disorders. For example, according to a 2022 report published by London Medical Laboratory, a UK-based provider of diagnostics and phlebotomy, 19% more people were expected to have significant hormone imbalances in 2022 compared to 2 years ago. Therefore, a surge in the incidence of hormone imbalance disorders will drive the hormone therapy industry.

What Is Driving The Hormone Therapy Market? Rising Aging Population Fuels Growth In The Hormone Therapy Market

The increasing number of elderly individuals is expected to propel the growth of the hormone therapy market in the coming years. Aged individuals are people who are in their later phases of life and are frequently connected with older people or the senior population. Hormone treatment in the elderly, particularly in the context of aging-related health disorders, aims to correct hormonal imbalances and manage specific aging-related illnesses. For instance, in July 2024, according to the UK Parliament, a UK-based government body, the population of the UK is expected to reach 70 million by 2026. Additionally, the population is aging, with 19% of people aged 65 or over in 2022. This figure is projected to rise to 27% by 2072. Therefore, the increasing number of elderly individuals is driving the hormone therapy industry.

Who Are The Major Players In The Global Hormone Therapy Market?

Major companies operating in the hormone therapy market include Abbott Laboratories, Bayer AG, Eli Lilly and Company, F. Hoffmann-La Roche, Merck KGaA, Mylan NV, Novartis AG, Novo Nordisk AS, Pfizer Inc., Abbvie Inc., Teva Pharmaceutical Industries Ltd., Perrigo Company Plc., Cipla Inc., Lupin Limited, Sun Pharmaceuticals Industries Ltd., Hikma Pharmaceuticals PLC., Johnsons & Johnsons Services Inc., Boehringer Ingelheim International GmbH, Sanofi S.A., AstraZeneca plc, TherapeuticsMD Inc., Amgen Inc., Genentech Inc., Dr. Reddy's Laboratories Ltd, Allergan PLC, GlaxoSmithKline plc, Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., Daiichi Sankyo Company Limited

What Are The Key Trends Of The Global Hormone Therapy Market? Innovative Direct-To-Consumer Telehealth Solutions Revolutionizing Hormone Therapy Accessibility

Major companies operating in the hormone therapy market are focusing on developing innovative solutions, such as direct-to-consumer telehealth models for hormone therapy, to enhance accessibility and convenience for patients. The direct-to-consumer telehealth model for hormone therapy refers to a healthcare delivery system that allows patients to access hormone therapy services remotely, without the need for traditional in-person consultations. For instance, in September 2023, LifeMD, a US-based telehealth company, partnered with ASCEND Therapeutics, a US-based pharmaceutical company, to launch an integrated direct-to-consumer telehealth model for hormone therapy, focusing on EstroGel (estradiol gel) to alleviate menopausal symptoms. This partnership allows patients to access LifeMD's telehealth services directly through the EstroGel website, facilitating consultations with licensed healthcare providers who can prescribe the medication and arrange home delivery. By streamlining access and addressing barriers such as long wait times, the initiative aims to enhance health outcomes for women seeking menopause treatment.

What Are The Key Trends Of The Global Hormone Therapy Market? Expanding Hormone Therapy Reach Strategic Partnership Targets North African And Middle Eastern Markets

Major companies operating in the hormone therapy market are adopting a strategic partnership approach aiming to commercialize hormone therapy in North African and Middle Eastern countries. Strategic partnerships refer to a process in which companies leverage each other's strengths and resources to achieve mutual benefits and success. For instance, in October 2023, Cosmo Pharmaceuticals N.V., an Ireland-based pharmaceutical company that manufactures hormonal drugs, announced a strategic agreement with Hikma Pharmaceuticals PLC. Hikma will get the exclusive right to register and market Winlevi in 17 Middle Eastern and North African countries from Cassiopeia, a subsidiary of Cosmo, under the terms of the deal. Cassiopea gets a USD 750,000 initial payment, as well as future regulatory and commercial milestones. Cassiopeia will be the sole provider of the product, with a price based on net sales. Hikma Pharmaceuticals PLC is a UK-based pharmaceutical company.

Need data on a specific region in this market?

Hormone Therapy Market Merger And Acquisition: Grünenthal Enhances Hormone Therapy Portfolio With Nebido Acquisition From Bayer Ag

In July 2022, Grünenthal Group, a Germany-based pharmaceutical company that manufactures hormone therapy drugs, acquired the testosterone treatment Nebido from Bayer AG for approximately $547.4 million. Through the acquisition, the brand is estimated to bring around $107.2 million to Grünenthal's EBITDA. The transaction is subject to usual closing conditions, which include clearance from the appropriate competition authorities. Bayer AG is a Germany-based pharmaceutical company providing hormone therapy and treatments.

Regional Analysis For The Global Hormone Therapy Market

North America was the largest region in the hormone therapy market in 2024. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Hormone Therapy Market?

The hormone therapy market includes revenues earned by entities by providing hormone therapies such as insulin therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Hormone Therapy Industry?

The hormone therapy market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the hormone therapy industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Hormone Therapy Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $20.9 billion
Revenue Forecast In 2034 $27.83 billion
Growth Rate CAGR of 7.4% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Therapy: Estrogen Hormone Replacement, Growth Hormone Replacement, Thyroid Hormone Replacement, Testosterone Replacement
2) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration
3) By Indication: Menopause, Hypothyroidism, Growth Hormone Deficiency, Other Indications
4) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies And Stores, Online Pharmacies Subsegments: 1) By Estrogen Hormone Replacement: Systemic Estrogen Therapy, Local Estrogen Therapy, Combination Estrogen-Progestin Therapy
2) By Growth Hormone Replacement: Recombinant Growth Hormones, Synthetic Growth Hormones
3) By Thyroid Hormone Replacement: Levothyroxine, Liothyronine, Natural Desiccated Thyroid
4) By Testosterone Replacement: Injectable Testosterone, Transdermal Testosterone, Oral Testosterone, Pellets
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Abbott Laboratories, Bayer AG, Eli Lilly and Company, F. Hoffmann-La Roche, Merck KGaA, Mylan NV, Novartis AG, Novo Nordisk AS, Pfizer Inc., Abbvie Inc., Teva Pharmaceutical Industries Ltd., Perrigo Company Plc., Cipla Inc., Lupin Limited, Sun Pharmaceuticals Industries Ltd., Hikma Pharmaceuticals PLC., Johnsons & Johnsons Services Inc., Boehringer Ingelheim International GmbH, Sanofi S.A., AstraZeneca plc, TherapeuticsMD Inc., Amgen Inc., Genentech Inc., Dr. Reddy's Laboratories Ltd, Allergan PLC, GlaxoSmithKline plc, Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., Daiichi Sankyo Company Limited
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Hormone Therapy Market Characteristics

3. Hormone Therapy Market Trends And Strategies

4. Hormone Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Hormone Therapy Growth Analysis And Strategic Analysis Framework

5.1. Global Hormone Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Hormone Therapy Market Growth Rate Analysis

5.4. Global Hormone Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Hormone Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Hormone Therapy Total Addressable Market (TAM)

6. Hormone Therapy Market Segmentation

6.1. Global Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Estrogen Hormone Replacement

Growth Hormone Replacement

Thyroid Hormone Replacement

Testosterone Replacement

6.2. Global Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Parenteral

Other Routes of Administration

6.3. Global Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Menopause

Hypothyroidism

Growth Hormone Deficiency

Other Indications

6.4. Global Hormone Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals Pharmacies

Retail Pharmacies And Stores

Online Pharmacies

6.5. Global Hormone Therapy Market, Sub-Segmentation Of Estrogen Hormone Replacement, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Systemic Estrogen Therapy

Local Estrogen Therapy

Combination Estrogen-Progestin Therapy

6.6. Global Hormone Therapy Market, Sub-Segmentation Of Growth Hormone Replacement, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Recombinant Growth Hormones

Synthetic Growth Hormones

6.7. Global Hormone Therapy Market, Sub-Segmentation Of Thyroid Hormone Replacement, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Levothyroxine

Liothyronine

Natural Desiccated Thyroid

6.8. Global Hormone Therapy Market, Sub-Segmentation Of Testosterone Replacement, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Injectable Testosterone

Transdermal Testosterone

Oral Testosterone

Pellets

7. Hormone Therapy Market Regional And Country Analysis

7.1. Global Hormone Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Hormone Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hormone Therapy Market

8.1. Asia-Pacific Hormone Therapy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hormone Therapy Market

9.1. China Hormone Therapy Market Overview

9.2. China Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hormone Therapy Market

10.1. India Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hormone Therapy Market

11.1. Japan Hormone Therapy Market Overview

11.2. Japan Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hormone Therapy Market

12.1. Australia Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hormone Therapy Market

13.1. Indonesia Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hormone Therapy Market

14.1. South Korea Hormone Therapy Market Overview

14.2. South Korea Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hormone Therapy Market

15.1. Western Europe Hormone Therapy Market Overview

15.2. Western Europe Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hormone Therapy Market

16.1. UK Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hormone Therapy Market

17.1. Germany Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hormone Therapy Market

18.1. France Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hormone Therapy Market

19.1. Italy Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hormone Therapy Market

20.1. Spain Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hormone Therapy Market

21.1. Eastern Europe Hormone Therapy Market Overview

21.2. Eastern Europe Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hormone Therapy Market

22.1. Russia Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hormone Therapy Market

23.1. North America Hormone Therapy Market Overview

23.2. North America Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hormone Therapy Market

24.1. USA Hormone Therapy Market Overview

24.2. USA Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hormone Therapy Market

25.1. Canada Hormone Therapy Market Overview

25.2. Canada Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hormone Therapy Market

26.1. South America Hormone Therapy Market Overview

26.2. South America Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hormone Therapy Market

27.1. Brazil Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hormone Therapy Market

28.1. Middle East Hormone Therapy Market Overview

28.2. Middle East Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hormone Therapy Market

29.1. Africa Hormone Therapy Market Overview

29.2. Africa Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hormone Therapy Market Competitive Landscape And Company Profiles

30.1. Hormone Therapy Market Competitive Landscape

30.2. Hormone Therapy Market Company Profiles

30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

30.2.4. F. Hoffmann-La Roche Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

31. Hormone Therapy Market Other Major And Innovative Companies

31.1. Mylan NV

31.2. Novartis AG

31.3. Novo Nordisk AS

31.4. Pfizer Inc.

31.5. Abbvie Inc.

31.6. Teva Pharmaceutical Industries Ltd.

31.7. Perrigo Company Plc.

31.8. Cipla Inc.

31.9. Lupin Limited

31.10. Sun Pharmaceuticals Industries Ltd.

31.11. Hikma Pharmaceuticals PLC.

31.12. Johnsons & Johnsons Services Inc.

31.13. Boehringer Ingelheim International GmbH

31.14. Sanofi S.A.

31.15. AstraZeneca plc

32. Global Hormone Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hormone Therapy Market

34. Recent Developments In The Hormone Therapy Market

35. Hormone Therapy Market High Potential Countries, Segments and Strategies

35.1 Hormone Therapy Market In 2029 - Countries Offering Most New Opportunities

35.2 Hormone Therapy Market In 2029 - Segments Offering Most New Opportunities

35.3 Hormone Therapy Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Hormone Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Hormone Therapy Market, Sub-Segmentation Of Estrogen Hormone Replacement, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Hormone Therapy Market, Sub-Segmentation Of Growth Hormone Replacement, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Hormone Therapy Market, Sub-Segmentation Of Thyroid Hormone Replacement, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Hormone Therapy Market, Sub-Segmentation Of Testosterone Replacement, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Hormone Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Hormone Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Abbott Laboratories Financial Performance
  • Table 80: Bayer AG Financial Performance
  • Table 81: Eli Lilly and Company Financial Performance
  • Table 82: F. Hoffmann-La Roche Financial Performance
  • Table 83: Merck KGaA Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Hormone Therapy Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Hormone Therapy Market, Sub-Segmentation Of Estrogen Hormone Replacement, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Hormone Therapy Market, Sub-Segmentation Of Growth Hormone Replacement, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Hormone Therapy Market, Sub-Segmentation Of Thyroid Hormone Replacement, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Hormone Therapy Market, Sub-Segmentation Of Testosterone Replacement, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Hormone Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Hormone Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Hormone Therapy Market, Segmentation By Therapy, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Hormone Therapy Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Hormone Therapy Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Abbott Laboratories Financial Performance
  • Figure 80: Bayer AG Financial Performance
  • Figure 81: Eli Lilly and Company Financial Performance
  • Figure 82: F. Hoffmann-La Roche Financial Performance
  • Figure 83: Merck KGaA Financial Performance

Frequently Asked Questions

Hormone therapy refers to a kind of treatment that alters, suppresses, or increases certain hormones in the body. Hormone therapy is used to treat hormonal imbalances such as hypothyroidism, and others. For further insights on this market, request a sample here

The market major growth driver - Surge In Hormone Imbalance Disorders Fuels Growth Of Hormone Therapy Market. For further insights on this market, request a sample here

The hormone therapy market size has grown strongly in recent years. It will grow from $19.7 billion in 2024 to $20.9 billion in 2025 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to medical advancements, women's health revolution, increased awareness and education, clinical research and development, shifting healthcare practices. The hormone therapy market size is expected to see strong growth in the next few years. It will grow to " $27.83 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to personalized medicine approach, aging population dynamics, shift in women's health approaches, focus on wellness and longevity, regulatory adaptations. Major trends in the forecast period include regulatory changes and guidelines, changing lifestyles and stress, research and development, expanding awareness and education. For further insights on this market, request a sample here

The hormone therapy market covered in this report is segmented –
1) By Therapy: Estrogen Hormone Replacement, Growth Hormone Replacement, Thyroid Hormone Replacement, Testosterone Replacement
2) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration
3) By Indication: Menopause, Hypothyroidism, Growth Hormone Deficiency, Other Indications
4) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies And Stores, Online Pharmacies Subsegments:
1) By Estrogen Hormone Replacement: Systemic Estrogen Therapy, Local Estrogen Therapy, Combination Estrogen-Progestin Therapy
2) By Growth Hormone Replacement: Recombinant Growth Hormones, Synthetic Growth Hormones
3) By Thyroid Hormone Replacement: Levothyroxine, Liothyronine, Natural Desiccated Thyroid
4) By Testosterone Replacement: Injectable Testosterone, Transdermal Testosterone, Oral Testosterone, Pellets For further insights on this market,
request a sample here

North America was the largest region in the hormone therapy market in 2024. The regions covered in the hormone therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on this market, request a sample here.

Major companies operating in the hormone therapy market include Abbott Laboratories, Bayer AG, Eli Lilly and Company, F. Hoffmann-La Roche, Merck KGaA, Mylan NV, Novartis AG, Novo Nordisk AS, Pfizer Inc., Abbvie Inc., Teva Pharmaceutical Industries Ltd., Perrigo Company Plc., Cipla Inc., Lupin Limited, Sun Pharmaceuticals Industries Ltd., Hikma Pharmaceuticals PLC., Johnsons & Johnsons Services Inc., Boehringer Ingelheim International GmbH, Sanofi S.A., AstraZeneca plc, TherapeuticsMD Inc., Amgen Inc., Genentech Inc., Dr. Reddy's Laboratories Ltd, Allergan PLC, GlaxoSmithKline plc, Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., Daiichi Sankyo Company Limited . For further insights on this market, request a sample here.

Major trends in this market include Innovative Direct-To-Consumer Telehealth Solutions Revolutionizing Hormone Therapy Accessibility. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top WhatsApp icon